Glaxosmithkline Pharmaceuticals (GSK Pharma) is currently trading at Rs. 2934.35, up by 465.95 points or 18.88% from its previous closing of Rs. 2468.40 on the BSE.
The scrip opened at Rs. 2949.90 and has touched a high and low of Rs. 2952.00 and Rs. 2900.00 respectively. So far 66476 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 2952.00 on 16-Dec-2013 and a 52 week low of Rs. 2005.00 on 01-Feb-2013.
Last one week high and low of the scrip stood at Rs. 2952.00 and Rs. 2427.25 respectively. The current market cap of the company is Rs. 24852.29 crore.
The promoters holding in the company stood at 50.67% while Institutions and Non-Institutions held 34.37% and 14.96% respectively.
GlaxoSmithKline Plc (GSK) is planning to hike its stake in its Indian pharmaceutical unit GlaxoSmithKline Pharmaceuticals to up to 75% from 50.7% through an open offer in a deal worth about 629 million pounds ($1.02 billion).
GSK would buy up to 20.6 million shares of the company at Rs 3,100 a share, a premium of 26 per cent over its closing market price on Friday. The company said that it planned to keep the Indian unit listed even after raising the stake.
GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1797.80 |
Dr. Reddys Lab | 1213.90 |
Cipla | 1486.30 |
Lupin | 2069.95 |
Zydus Lifesciences | 948.70 |
View more.. |